摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-Fluorophenyl)-2-morpholin-4-yl-2-thioxoacetamide | 635292-93-2

中文名称
——
中文别名
——
英文名称
N-(4-Fluorophenyl)-2-morpholin-4-yl-2-thioxoacetamide
英文别名
N-(4-fluorophenyl)-2-(morpholin-4-yl)-2-thioxoacetamide;N-(4-fluorophenyl)-2-morpholin-4-yl-2-sulfanylideneacetamide
N-(4-Fluorophenyl)-2-morpholin-4-yl-2-thioxoacetamide化学式
CAS
635292-93-2
化学式
C12H13FN2O2S
mdl
——
分子量
268.312
InChiKey
FWIWSWFCYYHMSR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    73.7
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    新型铜(II),钴(II)和镍(II)与5-(4-氧代-4H-铬-3-基)-4,5-二氢-1,3,4-噻二唑-2-羧酰胺的配合物:合成,结构,光谱学研究
    摘要:
    摘要一系列新颖的有机配体5-(4-oxo-4H-chromen-3-yl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxamide,是2-的互变异构形式。由3-甲酰基色酮和草酰胺合成了氧代-2-(芳基氨基)-(2E)-2-[(4-羟基-2-氧代-2H-1苯并吡喃-3-基)-亚甲基]乙硫酸酰肼酸硫酰肼。铜(II),钴(II)和镍(II)与2-oxo-2-(芳基氨基)-(2E)-2-[(4-羟基-2-oxo-2H-1-苯并吡喃-3-)的配合物通过相应的有机配体与MCl2(M = Cu,Co,Ni)的相互作用合成了yl)甲基亚烯基]乙硫基乙酰肼。与5-(4-氧代-4H-铬-3-基)-N-苯基-4,5-二氢-1,3,4-噻二唑-2-羧酰胺的铜(II)配合物的晶体结构为通过单晶X射线衍射法解决。复杂分子中的铜(II)离子由变形的三角双锥体几何结构中的醛亚胺氮原子,硫醇
    DOI:
    10.1016/j.poly.2017.10.027
  • 作为产物:
    参考文献:
    名称:
    源自 thiooxamohydrazides 和 3-formyl-4-hydroxycoumarin 的腙:合成、结构和断裂
    摘要:
    从 thiooxamohydrazides 和 3-3-formyl-4-hydroxycoumarin 中获得了新型腙。根据核磁共振谱和X射线衍射数据,所得化合物中的香豆素片段以4-羟基香豆素或色烷-2,4-二酮形式存在。当溶解在二甲亚砜中时,这些腙会分裂成 1,3,4-噻二唑和 4-羟基香豆素的衍生物。
    DOI:
    10.1007/s11172-012-0325-x
点击查看最新优质反应信息

文献信息

  • Novel copper(II), cobalt(II) and nickel(II) complexes with 5-(4-oxo-4H-chromen-3-yl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxamide: Synthesis, structure, spectroscopic studies
    作者:Ksenia A. Myannik、Vladimir N. Yarovenko、Elena K. Beloglazkina、Anna A. Moiseeva、Mikhail M. Krayushkin
    DOI:10.1016/j.poly.2017.10.027
    日期:2018.1
    Abstract A series of novel organic ligands, 5-(4-oxo-4H-chromen-3-yl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxamide, which are the tautomeric forms of 2-oxo-2-(arylamino)-(2E)-2- [(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-methyledene]ethanethioic acid hydrazides, have been synthesized from 3-formylchromone and oxamic acid thiohydrazides. Copper(II), cobalt(II) and nickel(II) complexes with 2-oxo-2-(ary
    摘要一系列新颖的有机配体5-(4-oxo-4H-chromen-3-yl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxamide,是2-的互变异构形式。由3-甲酰基色酮和草酰胺合成了氧代-2-(芳基氨基)-(2E)-2-[(4-羟基-2-氧代-2H-1苯并吡喃-3-基)-亚甲基]乙硫酸酰肼酸硫酰肼。铜(II),钴(II)和镍(II)与2-oxo-2-(芳基氨基)-(2E)-2-[(4-羟基-2-oxo-2H-1-苯并吡喃-3-)的配合物通过相应的有机配体与MCl2(M = Cu,Co,Ni)的相互作用合成了yl)甲基亚烯基]乙硫基乙酰肼。与5-(4-氧代-4H-铬-3-基)-N-苯基-4,5-二氢-1,3,4-噻二唑-2-羧酰胺的铜(II)配合物的晶体结构为通过单晶X射线衍射法解决。复杂分子中的铜(II)离子由变形的三角双锥体几何结构中的醛亚胺氮原子,硫醇
  • Synthesis of Oxamic Acids Thiohydrazides and Carbamoyl-1,3,4-thiadiazoles
    作者:V. N. Yarovenko、A. V. Shirokov、O. N. Krupinova、I. V. Zavarzin、M. M. Krayushkin
    DOI:10.1023/b:rujo.0000010181.01921.77
    日期:2003.8
    A convenient preparation method was developed for oxamic acids thiohydrazides by reaction of alpha-chloroacetamides with a preliminary prepared solution of elemental sulfur and hydrazines. A series of carbamoyl-1,3,4-thiadiazole derivatives was obtained.
  • Novel agonists of free fatty acid receptor 1 (GPR40) based on 3-(1,3,4-thiadiazol-2-yl)propanoic acid scaffold
    作者:Mikhail Krasavin、Alexey Lukin、Nikolay Zhurilo、Alexey Kovalenko、Ihor Zahanich、Sergey Zozulya
    DOI:10.3109/14756366.2016.1142984
    日期:2016.11.1
    1,3,4-Thiadiazole was explored as a more polar, heterocyclic replacement for the phenyl ring in the 3-arylpropionic acid pharmacophore present in the majority of GPR40 agonists. Out of 13 compounds synthesized using a flexible, three-step protocol (involving no chromatographic purification), four compounds were confirmed to activate the target in micromolar concentration range. While the potency of the series should be subject of further optimization, the remarkable aqueous solubility and microsomal stability observed for the lead compound (8g) apparently attests to this new scaffold's high promise in the GPR40 agonist field.
  • Novel free fatty acid receptor 1 (GPR40) agonists based on 1,3,4-thiadiazole-2-carboxamide scaffold
    作者:Mikhail Krasavin、Alexey Lukin、Nikolay Zhurilo、Alexey Kovalenko、Ihor Zahanich、Sergey Zozulya、Daniel Moore、Irina G. Tikhonova
    DOI:10.1016/j.bmc.2016.04.065
    日期:2016.7
    Free fatty acid receptor 1 (FFA1), previously known as GPR40 is a G protein-coupled receptor and a new target for treatment of type 2 diabetes. Two series of FFA1 agonists utilizing a 1,3,4-thiadiazole-2-caboxamide scaffold were synthetized. Both series offered significant improvement of the potency compared to the previously described 1,3,4-thiadiazole-based FFA1 agonists and high selectivity for FFA1. Molecular docking predicts new aromatic interactions with the receptor that improve agonist potency. The most potent compounds from both series were profiled for in vitro ADME properties (plasma and metabolic stability, Log D, plasma protein binding, hERG binding and CYP inhibition). One series suffered very rapid degradation in plasma and in presence of mouse liver microsomes. However, the other series delivered a lead compound that displayed a reasonable ADME profile together with the improved FFA1 potency. (C) 2016 Elsevier Ltd. All rights reserved.
  • Synthesis of Carbamoyl-Containing N,S-Heterocyclic Compounds
    作者:V. N. Yarovenko、A. A. Es'kov、I. V. Zavarzin、E. I. Chernoburova、A. Yu. Martynkin、M. M. Krayuskin
    DOI:10.1080/10426500307911
    日期:2003.6
    Monothioxamides unsubstituted at the thioamidic nitrogen atom were obtained by the reaction of NS-morpholino-NO-R-thioxamides with ammonia. Carbampyl-containing 5-phenylcarbamoyl-1,2,4-dithiazoles, 6-phenylcarbamoyl-5,6-dihydro-[1,2,4,5]-dithiadiazin-3-one, and 5-phenylcarbainoyl-2-oxy-1,3,4-thiadiazole were synthesized by the reaction of monothioxamides or thiohydrazides of oxamic acids with chlorocarbonylsulfenyl chloride.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物